Logo

People in the News: Kevin McKernan at Courtagen

Jan 20, 2012
Premium

Kevin McKernan has joined Courtagen Life Sciences as chief scientific officer.

McKernan was founder and CEO of Medicinal Genomics, which Courtagen acquired last month. Prior to that, McKernan was vice president and director of R&D at Life Technologies. He was also the co-founder, president, and CSO of Agencourt Personal Genomics.

Filed under

Proteomics & Protein Research
proteomics
Thermo Fisher Scientific
Courtagen
Breaking News
The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.